Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 1.000 | None | 1.000 | 1 | 6 | 2001 | 2019 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.700 | strong | 0.972 | 4 | 5 | 1998 | 2020 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.620 | strong | 1.000 | 0 | 0 | 2005 | 2017 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.430 | strong | 0.750 | 0 | 0 | 2015 | 2019 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
group | 0.410 | strong | 1.000 | 0 | 0 | 2005 | 2017 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 |